HVC
JAZZ icon

Healthcare Value Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Healthcare Value Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$1.65M – 25
2020
Q4 		$1.65M Sell
10,000
-15,000
-60% -$2.23M 5.56% 8
2020
Q3 		$3.56M Buy
25,000
+6,000
+32% +$744K 11.75% 2
2020
Q2 		$2.1M Sell
19,000
-11,000
-37% -$1.22M 5.35% 10
2020
Q1 		$2.99M Buy
+30,000
New +$3.88M 5.03% 11

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Healthcare Value Capital's JAZZ Position: Q1 2021 in Review

Healthcare Value Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2021, closing a stake of 10,000 shares — an estimated $1.65M sold.

Healthcare Value Capital first reported a position in JAZZ in Q1 2020 and held it in 4 quarters. The position peaked at $3.56M in Q3 2020. 442 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

  • Healthcare Value Capital reported no remaining Jazz Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Healthcare Value Capital sold 10,000 Jazz Pharmaceuticals shares in Q1 2021, an estimated $1.65M.
  • Healthcare Value Capital first reported a position in Jazz Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Healthcare Value Capital's Jazz Pharmaceuticals position peaked at $3.56M in Q3 2020.
  • 442 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on Healthcare Value Capital's 13F filing for Q1 2021, filed 17 May 2021.